Gilead breaks ground on new manufacturing hub as part of USD 32 billion US investment plan
Gilead Sciences has begun construction of a new Pharmaceutical Development and Manufacturing hub at its headquarters in Foster City, California, as part of a USD 32 billion investment programme to expand its manufacturing capabilities in the United States.
Pharmaceutical Development And Manufacturing | 05/09/2025 | By Darshana | 203
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy